Researchers from Case Western Reserve University School of Medicine report that semaglutide may reduce the risk of Alzheimer's disease in people with ...
The American Society of Health-System Pharmacists says there were 277 drug shortages as of September, down from an all-time high of 323.
An FDA safety alert warns about Regener-Eyes manufactured by Regenerative Processing Plant because the eye drops likely contain amniotic fluid.
FDA accepts for priority review a Telix NDA for Pixclara (18F-floretyrosine), a positron emission tomography agent for glioma imaging.
Alto Neuroscience says a study of its major depressive disorder investigational drug did not meet its primary endpoint.
Federal Register notice: FDA announces a 12/12 Vaccines and Related Biological Products Advisory Committee meeting to discuss considerations for pedia...
FDA warns Phoenix, AZ-based Pinnacle Transplant Technologies that it is illegally manufacturing and marketing amniotic products that have CGMP deviati...
Novo Nordisk asks FDA to add its semaglutide products to the lists of drugs that should not be compounded.
